According to filings with the U.S. Securities and Exchange Commission, Provisio Medical is raising up to $15,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Eric Ryan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Provisio Medical
Provisio Medical is working to revolutionize endovascular procedures through the development of Sonic Lumen Tomography (SLT), a novel intravascular ultrasound technology that provides accurate and precise real-time flow lumen dimensions. The SLT platform may also be easily integrated into many of the endovascular devices that physicians are already using today. Without the shortcomings of the low-resolution angiographys ionizing radiation and kidney-toxic contrast media, Provisios SLT platform looks to seamlessly provide physicians the exact information that they need, when they need it, to improve both clinical workflows and outcomes. With its SLT technology, Provisio is creating a new paradigm in intravascular measurements for assessing clinical presentation, guiding treatment decisions such as proper sizing of therapeutic endovascular devices, and confirming completion of treatment therapies.

To learn more about Provisio Medical, visit http://www.provisiomedical.com/
Provisio Medical Linkedin Page: https://www.linkedin.com/company/provisiomedical/

Contact:
Eric Ryan, President and Chief Executive Officer
858-524-3901
https://www.linkedin.com/in/s-eric-ryan-m-d-619ba335/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.